Your browser of choice has not been tested for use with If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More

Biotechnology Stocks

A list of publicly traded biotechnology and biotech-related stocks and ETFs.
Wed, Dec 6th, 2023

Biotechnology (biotech) Stocks are publicly traded companies that develop pharmaceutical drugs used in the treatment of disease. You can use Barchart's Biotech Stocks list to find investment opportunities and compare stocks involved in this hot industry.

View Profiles of these companies.

Biotechnology Stocks News

The Supreme Court wrestles with OxyContin maker's bankruptcy deal, with billions of dollars at stake

The Supreme Court is wrestling with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids...

OxyContin maker's settlement plan divides victims of opioid crisis. Now it's up to the Supreme Court

The legality of an agreement by the maker of OxyContin to settle thousands of lawsuits over the harm done by opioids is going before the Supreme Court

Big Pharma scrambles to feed demand for weight-loss treatments amid rising US obesity rates

Obesity rates in the U.S. have been rising steadily for well over a decade and some of the world’s biggest drug developers are tapping into the growing treatment market

GS : 341.75 (-2.19%)
NVS : 96.97 (-2.04%)
Vivek Ramaswamy's approach in business and politics is the same: Confidence, no matter the scenario

Vivek Ramaswamy's Republican presidential campaign has seemingly mirrored his meteoric rise as a biotech entrepreneur

EU orders biotech giant Illumina to unwind $7.1 billion purchase of cancer-screening company Grail

The European Union is ordering U.S. biotech giant Illumina to undo its $7.1 billion purchase of cancer-screening company Grail because it closed the deal without approval of regulators

$SPX : 4,567.18 (-0.06%)
$DOWI : 36,124.56 (-0.22%)
$IUXX : 15,877.71 (+0.24%)
Revolving door redux: The DEA's recently departed No. 2 returns to a Big Pharma consulting firm

Washington’s revolving door kept spinning this week as the Drug Enforcement Administration’s recently departed second-in-command returned for another stint with a high-powered consulting firm where...

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar